Find research datasets worth reusing
Search datasets from major research repositories and use ShareScore to quickly assess how well each record supports discovery, access, and reuse.
2,937
datasets available to search
ShareScore release 0.9.0
Dataset results
2,937 results for “Multiple Myeloma”
PD-L1 Peptide Vaccination in High Risk Smoldering Multiple Myeloma
ClinicalTrials.gov study NCT03850522. IPD Sharing: UNDECIDED. Countries: 1. Publications: 0.
Study of Bromodomain and Extra-Terminal Protein (BET) Inhibitor RO6870810 as Mono- and Combination Therapy in Advanced Multiple Myeloma
ClinicalTrials.gov study NCT03068351. IPD Sharing: Not stated. Countries: 3. Publications: 0.
Bendamustine Hydrochloride in Treating Patients With Previously Treated Multiple Myeloma
ClinicalTrials.gov study NCT02315157. IPD Sharing: Not stated. Countries: 1. Publications: 0.
A Phase 2, Single Arm Multicenter, Study Testing Mezigdomide, Carfilzomib, and Dexamethasone (480Kd) in Participants With Relapsed or Refractory Multiple Myeloma (RRMM)
ClinicalTrials.gov study NCT07348393. IPD Sharing: UNDECIDED. Countries: 1. Publications: 0.
a Study of CT0596 in Relapsed/Refractory Multiple Myeloma and Relapsed/Refractory Plasma Cell Leukemia
ClinicalTrials.gov study NCT06718270. IPD Sharing: Not stated. Countries: 1. Publications: 0.
Response-Based Dose Reduction of Linvoseltamab in the Treatment of Relapsed, Refractory, or Triple-Class Relapsed/Refractory Multiple Myeloma
ClinicalTrials.gov study NCT07181941. IPD Sharing: NO. Countries: 1. Publications: 0.
Tocladesine in Treating Patients With Recurrent or Refractory Multiple Myeloma
ClinicalTrials.gov study NCT00004902. IPD Sharing: Not stated. Countries: 1. Publications: 0.
Efficacy of 68Ga-Pentixafor PET/MR in Detecting Non-Hodgkin Lymphoma and Multiple Myeloma Lesions
ClinicalTrials.gov study NCT06720207. IPD Sharing: NO. Countries: 0. Publications: 0.
PET/MR Scan With [68Ga]Ga-PentixaFor (CXCR4) vs Standard of Care (SOC) for Initial Staging and Follow up in Multiple Myeloma (MM)
ClinicalTrials.gov study NCT06871176. IPD Sharing: Not stated. Countries: 1. Publications: 0.
Safety and Tolerability Study of SNS01-T in Relapsed or Refractory B Cell Malignancies (Multiple Myeloma, B Cell Lymphoma, or Plasma Cell Leukemia (PCL)
ClinicalTrials.gov study NCT01435720. IPD Sharing: Not stated. Countries: 2. Publications: 0.
Daratumumab Combined With Bortezomib, Cyclophosphamide and Dexamethasone for the Treatment of Multiple Myeloma Patients Presenting With Extramedullary Disease
ClinicalTrials.gov study NCT04166565. IPD Sharing: NO. Countries: 3. Publications: 0.
ON 123300 (Narazaciclib) and Dexamethasone in Patients With Relapsed and/or Refractory Multiple Myeloma
ClinicalTrials.gov study NCT06351644. IPD Sharing: YES. Countries: 1. Publications: 0.
B Cell Maturation Antigen Targeted CAR-T Cells in Treatment With Relapsed and Refractory Multiple Myeloma
ClinicalTrials.gov study NCT05150522. IPD Sharing: NO. Countries: 1. Publications: 0.
Chemoprevention Therapy in Treating Patients at High Risk of Developing Multiple Myeloma
ClinicalTrials.gov study NCT00006219. IPD Sharing: Not stated. Countries: 1. Publications: 0.
Minimal Residual Disease-based Strategy with T-Cell Redirector After Treatment with Daratumumab, Bortezomib, Lenalidomide, and Dexamethasone (D-VRd) in Newly Diagnosed Multiple Myeloma
ClinicalTrials.gov study NCT06353022. IPD Sharing: Not stated. Countries: 1. Publications: 0.
A Study Evaluating the Safety, Pharmacokinetics, and Activity of the Combination of Cevostamab and Elranatamab in Participants With Relapsed or Refractory Multiple Myeloma (R/R MM)
ClinicalTrials.gov study NCT05927571. IPD Sharing: YES. Countries: 3. Publications: 0.
Protein Tyrosine Kinases (PTK) in Multiple Myeloma
ClinicalTrials.gov study NCT00165347. IPD Sharing: Not stated. Countries: 1. Publications: 0.
Chemotherapy and Peripheral Stem Cell Transplantation Followed By Immunotherapy in Treating Patients With Multiple Myeloma
ClinicalTrials.gov study NCT00046852. IPD Sharing: Not stated. Countries: 1. Publications: 0.
A Clinical Study Comparing SG301 Plus Pomalidomide and Dexamethasone to Placebo Plus Pomalidomide and Dexamethasone in Relapsed or Refractory Multiple Myeloma Patients
ClinicalTrials.gov study NCT06508983. IPD Sharing: Not stated. Countries: 1. Publications: 0.
All-trans Retinoic Acid in Combination With a KPD Regimen for the Treatment of Refractory/Relapsed Multiple Myeloma
ClinicalTrials.gov study NCT06158412. IPD Sharing: NO. Countries: 1. Publications: 0.
ScienceDex guides
Understand access before you commit
These curated guides explain access requirements, typical timelines, costs, and reuse considerations for widely used research datasets.
Allen Brain Atlas
Allen Brain Atlas is an Allen Institute collection of brain map atlases, datasets, APIs, and analysis tools covering mouse, human, and non-human primate brain resources.
Annotated Behaviour and Observability Dataset (ABODe)
ABODe is a University of Edinburgh DataShare dataset for behavior classification in group-housed mice using home-cage video, identities, bounding boxes, ground-plate positions, and annotator labels.
DANDI Archive for NWB datasets
DANDI is a BRAIN Initiative archive for publishing and sharing neurophysiology data, including electrophysiology, optophysiology, and behavioral data packaged as NWB and related standards.
International Brain Laboratory public data
The International Brain Laboratory public data releases expose standardized mouse decision-making experiments, including Neuropixels recordings, widefield calcium imaging, behavior, and session metadata accessed through the ONE API.
OpenNeuro
OpenNeuro is a free, open platform for sharing neuroimaging datasets, with public search, dataset pages, and download paths for web, S3, DataLad, and the OpenNeuro CLI.